UT Southwestern Medical Center: Preclinical Study Suggests Organ-Transplant Drug May Aid in Lupus Fight
DALLAS — Aug. 15, 2007 — A compound related to a drug used in humans to prevent organ-transplant rejection attacks a key biochemical process in the faulty immune cells of lupus-prone mice, suggesting a possible new approach to combating the disease, UT Southwestern Medical Center researchers have found.